Richard P. Marshall

17.1k citations

72 papers · 6.1k indexed · 3 hit papers · h-index 36

Pulmonary and Respiratory Medicine top 0.5%
Physiology top 0.5%
Immunology and Allergy top 0.5%
Surgery top 5%
Immunology top 5%

Co-authors: Geoffrey J. Laurent Robin J. McAnulty Ana R. Sousa Christopher E. Brightling Sumit Gupta Ian Pavord William Monteiro Andrew J. Wardlaw
Topics: Posttraumatic Stress Disorder Research (21 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (20 papers)Inhalation and Respiratory Drug Delivery (13 papers)
Cited by: Immunology and Allergy Otorhinolaryngology Physiology
Journals: New England Journal of Medicine The Lancet Nature Reviews Drug Discovery
Partner nations: United Kingdom Australia United States

In The Last Decade

Richard P. Marshall

71 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

2009 1.4k citations Christopher E. Brightling, Sumit Gupta et al. profile →
Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis

2011 457 citations Ana R. Sousa, Richard P. Marshall et al. profile →
Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial

2017 352 citations Ana R. Sousa, Richard P. Marshall et al. profile →

Peers

Countries citing papers authored by Richard P. Marshall

Since Specialization

Citations

This map shows the geographic impact of Richard P. Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard P. Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard P. Marshall more than expected).

Fields of papers citing papers by Richard P. Marshall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard P. Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard P. Marshall. The network helps show where Richard P. Marshall may publish in the future.

Co-authorship network of co-authors of Richard P. Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of Richard P. Marshall. A scholar is included among the top collaborators of Richard P. Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard P. Marshall. Richard P. Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Transcriptome analysis of IPF fibroblastic foci identifies key pathways involved in fibrogenesis 2020 ·Thorax ·Delphine Guillotin,Adam Taylor,Manuela Platé,Paul F. Mercer,Lindsay M. Edwards,(unknown),Gino Miele,Robin J. McAnulty,Toby M. Maher,Robert E. Hynds,Mariam Jamal‐Hanjani,Richard P. Marshall,Andrew J. Fisher,Andy Blanchard,Rachel C. Chambers	28
2	Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort 2019 ·Respiratory Research ·Louise Organ,(unknown),Eunice Oballa,(unknown),Juliet K. Simpson,Arthur R Kang’ombe,Rebecca Braybrooke,Philip L. Molyneaux,Bernard V. North,(unknown),Diana Julie Leeming,M.A. Karsdal,Carmel B. Nanthakumar,William A. Fahy,Richard P. Marshall,Gísli Jenkins,Toby M. Maher	88
3	Discovery of (S)-3-(3-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)-4-((R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic α_vβ₆ Integrin Inhibitor for the Inhaled Treatment of Idiopathic Pulmonary Fibrosis 2018 ·Journal of Medicinal Chemistry ·Panayiotis A. Procopiou,Niall A. Anderson,John W. Barrett,(unknown),(unknown),Brendan J. Fallon,Ashley P. Hancock,Joelle Le,(unknown),Richard P. Marshall,(unknown),John M. Pritchard,James E. Rowedder,(unknown),Robert J. Slack,Steven L. Sollis,Colin J. Suckling,(unknown),Giovanni Vitulli,Simon J. F. Macdonald	31
4	Associations in asthma between quantitative computed tomography and bronchial biopsy-derived airway remodelling 2017 ·European Respiratory Journal ·Rachid Berair,Ruth Hartley,Vijay Mistry,Ajay Sheshadri,Sumit Gupta,Amisha Singapuri,Sherif Gonem,Richard P. Marshall,Ana R. Sousa,Aarti Shikotra,Richard Kay,Andrew J. Wardlaw,Peter Bradding,Salman Siddiqui,Mario Castro,Christopher E. Brightling	31
5	Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis 2016 ·American Journal of Respiratory and Critical Care Medicine ·Anne‐Marie Russell,Huzaifa Adamali,Philip L. Molyneaux,Pauline T. Lukey,Richard P. Marshall,Elisabetta Renzoni,Athol U. Wells,Toby M. Maher	114
6	Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF 2016 ·Thorax ·Paul F. Mercer,Hannah V. Woodcock,Jessica Eley,Manuela Platé,Michal Sulikowski,Pascal F. Durrenberger,Linda A. Franklin,Carmel B. Nanthakumar,Yim Man,Federica Genovese,Robin J. McAnulty,Shuying Yang,Toby M. Maher,Andrew G. Nicholson,Andy Blanchard,Richard P. Marshall,Pauline T. Lukey,Rachel C. Chambers	154
7	Functional Prostaglandin-Endoperoxide Synthase 2 Polymorphism Predicts Poor Outcome in Sarcoidosis 2006 ·American Journal of Respiratory and Critical Care Medicine ·Michael Hill,Anastasia Papafili,Helen Booth,(unknown),(unknown),Huw Beynon,Catherine Read,Gisela Lindahl,Richard P. Marshall,Robin J. McAnulty,Geoffrey J. Laurent	47
8	The Pulmonary Renin-Angiotensin System 2003 ·Current Pharmaceutical Design ·Richard P. Marshall	110
9	Angiotensin Converting Enzyme Insertion/Deletion Polymorphism Is Associated with Susceptibility and Outcome in Acute Respiratory Distress Syndrome 2002 ·American Journal of Respiratory and Critical Care Medicine ·Richard P. Marshall,Suzanne Webb,Geoffrey Bellingan,Hugh Montgomery,(unknown),Robin J. McAnulty,Steve E. Humphries,Mike Hill,Geoffrey J. Laurent	299
10	The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats: Fig. 1.— 2002 ·European Respiratory Journal ·(unknown),David C. Howell,Richard P. Marshall,Neil Goldsack,P S Hasleton,Geoffrey J. Laurent,Rachel C. Chambers,J. Egan	80
11	Direct Thrombin Inhibition Reduces Lung Collagen, Accumulation, and Connective Tissue Growth Factor mRNA Levels in Bleomycin-Induced Pulmonary Fibrosis 2001 ·American Journal Of Pathology ·David C. Howell,Neil Goldsack,Richard P. Marshall,Robin J. McAnulty,Richard Starke,G. Purdy,Geoffrey J. Laurent,Rachel C. Chambers	149
12	Angiotensin II Is Mitogenic for Human Lung Fibroblasts via Activation of the Type 1 Receptor 2000 ·American Journal of Respiratory and Critical Care Medicine ·Richard P. Marshall,Robin J. McAnulty,Geoffrey J. Laurent	177
13	Fibroproliferation Occurs Early in the Acute Respiratory Distress Syndrome and Impacts on Outcome 2000 ·American Journal of Respiratory and Critical Care Medicine ·Richard P. Marshall,Geoffrey Bellingan,Suzanne Webb,(unknown),Neil Goldsack,Robin J. McAnulty,Geoffrey J. Laurent	213
14	Comparing Sample Surveys of Health with Official Population Statistics: Some Methodological Issues and Empirical Findings 1999 ·Journal of Official Statistics ·Brian I. O’Toole,Richard P. Marshall,Ralph J. Schureck,Matthew Dobson	1
15	Combat, dissociation, and posttraumatic stress disorder in Australian Vietnam veterans 1999 ·Journal of Traumatic Stress ·Brian I. O’Toole,Richard P. Marshall,Ralph J. Schureck,Matthew Dobson	52
16	Current combat-related disorders in the absence of PTSD among Australian Vietnam veterans 1998 ·Social Psychiatry and Psychiatric Epidemiology ·David Grayson,Matthew Dobson,Richard P. Marshall	11
17	Help-seeking in Vietnam veterans: post-traumatic stress disorder and other predictors 1997 ·Australian and New Zealand Journal of Public Health ·Richard P. Marshall,Anthony F. Jorm,David Grayson,Matthew Dobson,Brian I. O’Toole	19
18	Interviewer Effects on Epidemiologic Diagnoses of Posttraumatic Stress Disorder 1996 ·American Journal of Epidemiology ·David Grayson,Brian I. O’Toole,Richard P. Marshall,Ralph J. Schureck,Matthew Dobson,Margot Ffrench,(unknown),(unknown)	15
19	The Australian Vietnam Veterans Health Study: II. Self-Reported Health of Veterans Compared with the Australian Population 1996 ·International Journal of Epidemiology ·Brian I. O’Toole,Richard P. Marshall,David Grayson,Ralph J. Schureck,Matthew Dobson,Margot Ffrench,(unknown),Lenore Meldrum,(unknown),(unknown)	45
20	The Australian Vietnam Veterans Health Study: I. Study Design and Response Bias 1996 ·International Journal of Epidemiology ·Brian I. O’Toole,Richard P. Marshall,David Grayson,Ralph J. Schureck,Matthew Dobson,Margot Ffrench,(unknown),Lenore Meldrum,(unknown),(unknown)	36

About Richard P. Marshall

Richard P. Marshall is a scholar working on Pulmonary and Respiratory Medicine, Clinical Psychology and Immunology and Allergy, having authored 72 papers that have together received 6.1k indexed citations. Recurring topics across this work include Posttraumatic Stress Disorder Research (21 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (20 papers) and Inhalation and Respiratory Drug Delivery (13 papers). The work is most often cited by research in Immunology and Allergy (944 citations), Otorhinolaryngology (560 citations) and Physiology (2.4k citations). Richard P. Marshall has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Geoffrey J. Laurent, Robin J. McAnulty, Ana R. Sousa, Christopher E. Brightling, Sumit Gupta, Ian Pavord, William Monteiro, Andrew J. Wardlaw, Peter Bradding and Pranabashis Haldar. Their work appears in journals such as New England Journal of Medicine, The Lancet and Nature Reviews Drug Discovery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact